Autoantibodies are already observed to become biomarkers for future neuropsychiatric events in SLE. A possible study of 1047 SLE people shown that individuals who had evidence of lupus anticoagulant (LA) experienced an increased potential hazard of intracranial thrombosis Which These with anti-ribosomal P antibodies had an increased potential possibility https://edgarkxwfa.estate-blog.com/37512879/lupus-diagnosis-no-further-a-mystery